Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin-assisted psychotherapy for sex addiction
2026-527083-32-00Phase 2Authorised
- Sponsor
- CHU de Nantes
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of psilocybin in hypersexuality (2 arms), sponsored by CHU de Nantes. Primary endpoint: Protocol completion rate. Planned start Oct 2026; status: authorised.
02
Drugs
psilocybin
03
Conditions
hypersexuality
Beyond the preview
Go deeper on 2026-527083-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-527083-32-00.